# Oxify (Lidocaine 5%) by Weeks & Leo Compnay, INC.: new human otc drug listing

**Launch Signal Score:** 15/100

| Field | Value |
|---|---|
| Product | Oxify |
| Generic name | Lidocaine 5% |
| NDC | 11383-331 |
| Labeler | Weeks & Leo Compnay, INC. |
| Product type | HUMAN OTC DRUG |
| Approval pathway | OTC MONOGRAPH DRUG |
| Application number | M015 |
| Dosage form | CREAM |
| Route | TOPICAL |
| Active ingredients | LIDOCAINE 50 mg/g |
| Marketing start | 2026-10-06 |
| Package configurations | 1 |

## Why this score


Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=11383-331). Last refreshed: 2026-11-03T18:09:00.764Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.